Farther Finance Advisors’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.6K Sell
454
-129
-22% -$8.39K ﹤0.01% 3296
2026
Q1
$28.9K Buy
583
+247
+74% +$11.1K ﹤0.01% 3396
2025
Q4
$10.6K Sell
336
-230
-41% -$7.18K ﹤0.01% 3865
2025
Q3
$15.9K Sell
566
-4,394
-89% -$133K ﹤0.01% 3176
2025
Q2
$182K Sell
4,960
-1,475
-23% -$51K ﹤0.01% 1441
2025
Q1
$251K Buy
6,435
+1,006
+19% +$45.3K 0.01% 1135
2024
Q4
$252K Buy
5,429
+2,028
+60% +$91.6K 0.01% 882
2024
Q3
$154K Buy
3,401
+3,134
+1,174% +$149K 0.01% 1108
2024
Q2
$13.1K Buy
267
+115
+76% +$4.69K ﹤0.01% 1961
2024
Q1
$5.23K Buy
152
+38
+33% +$1.37K ﹤0.01% 2044
2023
Q4
$4.2K Buy
114
+92
+418% +$2.13K ﹤0.01% 2058
2023
Q3
$446 Hold
22
﹤0.01% 2301
2023
Q2
$450 Buy
+22
New +$330 ﹤0.01% 2181
2023
Q1
Sell
-9
Closed -$214 2428
2022
Q4
$214 Buy
+9
New +$261 ﹤0.01% 2031

Other funds holding TWST

Farther Finance Advisors's TWST Position: Q2 2026 in Review

Farther Finance Advisors reduced its Twist Bioscience (TWST) stake by 22% in Q2 2026, selling an estimated $8.39K and leaving 454 shares worth $46.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3296.

Farther Finance Advisors first reported a position in TWST in Q4 2022 and has held it in 14 quarters since. The position peaked at $252K in Q4 2024. 33 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Farther Finance Advisors held 454 shares of Twist Bioscience worth $46.6K as of Q2 2026.
  • Farther Finance Advisors sold 129 Twist Bioscience shares in Q2 2026, an estimated $8.39K.
  • Twist Bioscience made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3296 holding.
  • Farther Finance Advisors first reported a position in Twist Bioscience in Q4 2022 and has held it in 14 quarters since.
  • Farther Finance Advisors's Twist Bioscience position peaked at $252K in Q4 2024.
  • 33 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.